High-Dose Ursodeoxycholic Acid Increases Risk of Adverse Outcomes in Patients With Early Stage Primary Sclerosing Cholangitis

Alimentary Pharmacology and Therapeutics- United Kingdom

doi 10.1111/j.1365-2036.2011.04863.x

Full Text

Abstract

Available in

Date

Authors

Publisher

Wiley

Related search

Ursodeoxycholic Acid as a Chemopreventive Agent in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis

Gastroenterology
HepatologyGastroenterology
2003English

Primary Sclerosing Cholangitis Response to the Combination of Fibrates With Ursodeoxycholic Acid: French–Spanish Experience

Clinics and Research in Hepatology and Gastroenterology
HepatologyGastroenterology
2018English

Primary Sclerosing Cholangitis

2020English

Primary Sclerosing Cholangitis

2017English

Primary Sclerosing Cholangitis

2012English

Primary Sclerosing Cholangitis

2013English

Surveillance for Hepatobiliary Cancers in Patients With Primary Sclerosing Cholangitis

Hepatology
MedicineHepatology
2018English

Lack of Standardization in Exception Points for Patients With Primary Sclerosing Cholangitis and Bacterial Cholangitis

American Journal of Transplantation
TransplantationAllergyImmunologyPharmacology
2012English

Cost Effectiveness of Using Ursodeoxycholic Acid to Treat Primary Biliary Cholangitis

British journal of hospital medicine (London, England : 2005)
Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy